Just told my Melanoma is inoperable — what does that mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding "Inoperable" Melanoma
I'm sorry you're facing this diagnosis. Let me explain what "inoperable" means and what treatment options are available to you.
What "Inoperable" Means
When doctors say melanoma is "inoperable" (also called unresectable or borderline resectable), it means the cancer cannot be safely removed with surgery alone. This might be because:
- The tumor is in a location where surgery would cause significant harm to surrounding tissues or organs
- The cancer has spread in a way that makes complete surgical removal impossible
- The tumor is too large or in too many locations to remove safely
Important: This is NOT the same as saying the cancer is untreatable. There are many effective treatment options available.
Your Treatment Options
According to the NCCN Guidelines for Patients: Melanoma, when melanoma is unresectable or borderline resectable, the preferred initial treatment approaches include:
Systemic Therapy (First-Line Treatment)
This means cancer-fighting drugs that work throughout your whole body:
- Immunotherapy - drugs that help your immune system recognize and attack cancer cells (examples: nivolumab, pembrolizumab)
- Targeted therapy - if your cancer has specific genetic mutations like BRAF V600, drugs like dabrafenib/trametinib may be used
Local Therapy Options
These treat cancer in specific areas:
- T-VEC (talimogene laherparepvec) - an intralesional therapy that uses a modified virus to infect and kill cancer cells while sparing healthy cells
- Interleukin-2 (IL-2) - an injectable immunotherapy used in some cases
- Radiation therapy - high-energy rays targeted at tumors
Regional Therapy
For melanoma confined to an arm or leg:
- Isolated Limb Infusion/Perfusion (ILI/ILP) - a specialized procedure where high-dose chemotherapy is delivered directly to the affected limb. This should only be done at centers experienced with this technique.
Supportive Care (Palliation)
Treatment focused on managing symptoms and maintaining quality of life, which may include limited surgery or local ablation (minimally invasive techniques).
What Happens Next
Your care team will likely:
- Assess your cancer's characteristics - including whether you have specific genetic mutations (like BRAF) that affect treatment choices
- Determine your response to treatment - through imaging and physical exams
- Adjust your plan - based on how your cancer responds
According to NCCN Guidelines, after initial treatment, if there's no evidence of disease remaining, you may move to adjuvant (follow-up) therapy options like nivolumab or pembrolizumab to help prevent recurrence.
Questions to Ask Your Oncology Team
To help you engage in shared decision-making about your care:
- What type of melanoma do I have, and has it been tested for genetic mutations like BRAF?
- Which treatment approach do you recommend for my specific situation, and why?
- What are the potential benefits and side effects of each treatment option?
- How will we measure whether the treatment is working?
- Are there clinical trials available that might be appropriate for me?
- How often will I need appointments, and what should I expect during treatment?
Important Perspective
The fact that your melanoma is inoperable does NOT mean it's untreatable. Modern immunotherapy and targeted therapy have significantly improved outcomes for advanced melanoma. Many patients with unresectable melanoma respond well to systemic treatment and may eventually have surgery if the cancer shrinks enough to become resectable.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Melanoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Melanoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: